Breast Cancer Research and Treatment

, Volume 90, Issue 3, pp 273–280 | Cite as

Dual role of AP-2γ in ErbB-2-induced mammary tumorigenesis

  • Richard Jäger
  • Nicolaus Friedrichs
  • Inge Heim
  • Reinhard Büttner
  • Hubert Schorle


A causative role of the membrane-bound tyrosine kinase ErbB-2 in breast tumorigenesis has been well established. MMTV/neu transgenic mice which overexpress ErbB-2 consistently develop mammary carcinomas with a high incidence. In human breast cancer, ErbB-2 is overexpressed in 25–30 of all cases and is representing a clinical marker of a poor prognosis. Besides to gene amplification, ErbB-2 overexpression has been attributed to transcription factors of the AP-2 family which were shown to control the ErbB-2 gene promoter in cell culture studies. Particularly AP-2α and γ are often coexpressed in ErbB-2-positive breast carcinomas. However, LTRγ transgenic mice which overexpress AP-2γ in their mammary epithelium display only a very weak upregulation of the erbB-2 gene and do not develop mammary carcinoma. These findings therefore raise the possibility of functional cooperativity between both genes in breast cancer. To experimentally address the impact of AP-2γon ErbB-2-induced breast carcinogenesis we crossed MMTV/neu transgenic mice with LTRγ transgenic mice and monitored tumor development in bitransgenic female progeny. AP-2γ overexpression negatively influenced tumor incidence, as reflected by a reduced tumor number and a prolonged tumor latency. Histological analysis revealed three major types of tumors corresponding to different stages of tumor progression. Interestingly, an increased proportion of advanced stage carcinomas was observed in bitransgenic mice. Moreover, the AP-2γ transgene differentially affected proliferation rates between the different progression stages: proliferation was enhanced at early stages but reduced in advanced stages in comparison to control tumors. Therefore, AP-2γ while reducing the incidence of mammary tumors is promoting tumor progression.


AP-2 breast cancer erbB-2 mammary transgenic mice tumor progression 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hilger-Eversheim, K, Moser, M, Schorle, H, Buettner, R 2000Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle controlGene260112Google Scholar
  2. 2.
    Zhao, F, Satoda, M, Licht, JD, Hayashizaki, Y, Gelb, BD 2001Cloning and characterization of a novel mouse ap-2 transcription factor, ap-2delta, with unique DNA binding and transactivation propertiesJ Biol Chem2764075540760Google Scholar
  3. 3.
    Feng, W, Williams, T 2003Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the olfactory bulbMol Cell Neurosci24460475Google Scholar
  4. 4.
    Tummala, R, Romano, RA, Fuchs, E, Sinha, S 2003Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 familyGene32193102Google Scholar
  5. 5.
    McPherson, LA, Baichwal, VR, Weigel, RJ 1997Identification of ERF-1 as a member of the AP2 transcription factor familyProc Natl Acad Sci USA9443424347Google Scholar
  6. 6.
    Bosher, JM, Williams, T, Hurst, HC 1995The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinomaProc Natl Acad Sci USA92744747Google Scholar
  7. 7.
    Bosher, JM., Totty, NF, Hsuan, JJ, Williams, T, Hurst, HC 1996A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinomaOncogene1317011707Google Scholar
  8. 8.
    Turner, BC, Zhang, J, Gumbs, AA, Maher, MG, Kaplan, L, Carter, D, Glazer, PM, Hurst, HC, Haffty, BG, Williams, T 1998Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathwaysCancer Res5854665472Google Scholar
  9. 9.
    Holbro, T, Hynes, NE 2004ErbB receptors: directing key signaling networks throughout lifeAnnu Rev Pharmacol Toxicol44195217Google Scholar
  10. 10.
    Eccles, SA 2002The role of c-erbB-2/HER2/neu in breast cancer progression and metastasisJ Mammary Gland Biol Neoplasia6393406Google Scholar
  11. 11.
    Guy, CT, Webster, MA, Schaller, M, Parsons, TJ, Cardiff, RD, Muller, WJ 1992Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic diseaseProc Natl Acad Sci USA891057810582Google Scholar
  12. 12.
    Muller, WJ, Sinn, E, Pattengale, PK, Wallace, R, Leder, P 1988Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogeneCell54105115Google Scholar
  13. 13.
    Bouchard, L, Lamarre, L, Tremblay, PJ, Jolicoeur, P 1989Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogeneCell57931936Google Scholar
  14. 14.
    Andrechek, ER, Hardy, WR, Siegel, PM, Rudnicki, MA, Cardiff, RD, Muller, WJ 2000Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesisProc Natl Acad Sci USA9734443449Google Scholar
  15. 15.
    Troyer, KL, Lee, DC 2001Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling networkJ Mammary Gland Biol Neoplasia6721Google Scholar
  16. 16.
    Bates, NP, Hurst, HC 1997Transcriptional regulation of Type I receptor tyrosine kinases in the mammary glandJ Mammary Gland Biol Neoplasia2153163Google Scholar
  17. 17.
    Hurst, HC 2001Update on HER-2 as a target for cancer therapy. The ERBB2 promoter and its exploitation for cancer treatmentBreast Cancer Res3395398Google Scholar
  18. 18.
    Perissi, V, Menini, N, Cottone, E, Capello, D, Sacco, M, Montaldo, F, Bortoli, M 2000AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogenOncogene19280288Google Scholar
  19. 19.
    Vernimmen, D, Begon, D, Salvador, C, Gofflot, S, Grooteclaes, M, Winkler, R 2003Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpressionBiochem J.370323329Google Scholar
  20. 20.
    Williamson, JA 1996Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factorsGenomics35262264Google Scholar
  21. 21.
    Zhao, C, Yasui, K, Lee, CJ, Kurioka, H, Hosokawa, Y, Oka, T, Inazawa, J 2003Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosisCancer981823Google Scholar
  22. 22.
    Jäger, R, Werling, U, Rimpf, S, Jacob, A, Schorle, H 2003Transcription factor AP-2γ stimulates proliferation and apoptosis and impairs differentiation in a transgenic modelMol Cancer Res1921929Google Scholar
  23. 23.
    Li, B, Rosen, JM, McMenamin-Balano, J, Muller, WJ, Perkins, AS 1997neu/ERBB2 cooperates with p53–172H during mammary tumorigenesis in transgenic miceMol Cell Biol.1731553163Google Scholar
  24. 24.
    Chirgwin, JM, Przybyla, AE, MacDonald, RJ, Rutter, WJ 1979Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry18529452999Google Scholar
  25. 25.
    Munarini, N, Jäger, R, Abderhalden, S, Zuercher, G, Rohrbach, V, Loercher, S, Pfanner-Meyer, B, Andres, AC, Ziemiecki, A 2002Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinaseJ Cell Sci.1152537Google Scholar
  26. 26.
    Cardiff, RD, Sinn, E, Muller, W, Leder, P 1991Transgenic oncogene mice. Tumor phenotype predicts genotypeAm J Pathol139495501Google Scholar
  27. 27.
    Rosner, A, Miyoshi, K, Landesman-Bollag, E, Xu, X, Seldin, DC, Moser, AR, MacLeod, CL, Shyamala, G, Gillgrass, AE, Cardiff, RD 2002Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumorsAm J Pathol16110871097Google Scholar
  28. 28.
    Lazar, H, Baltzer, A, Gimmi, C, Marti, A, Jaggi, R 2000Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosisInt J Cancer855785783Google Scholar
  29. 29.
    Pellikainen, J, Naukkarinen, A, Ropponen, K, Rummukainen, J, Kataja, V, Kellokoski, J, Eskelinen, M, Kosma, VM 2004Expression of HER2 and its association with AP-2 in breast cancerEur J Cancer4014851495Google Scholar
  30. 30.
    Gee, JM, Robertson, JF, Ellis, IO, Nicholson, RI, Hurst, HC 1999Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancerJ Pathol189514520Google Scholar
  31. 31.
    Pellikainen, J, Kataja, V, Ropponen, K, Kellokoski, J, Pietilainen, T, Bohm, J, Eskelinen, M, Kosma, VM 2002Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancerClin Cancer Res834873495Google Scholar
  32. 32.
    Zhang, J, Brewer, S, Huang, J, Williams, T 2003Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesisDev Biol25612745Google Scholar
  33. 33.
    Rowse, GJ, Ritland, SR, Gendler, SJ 1998Genetic modulation of neu proto-oncogene-induced mammary tumorigenesisCancer Res5826752679Google Scholar
  34. 34.
    Di Carlo, E, Diodoro, MG, Boggio, K, Modesti, A, Modesti, M, Nanni, P, Forni, G, Musiani, P 1999Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular originLab Invest7912611269Google Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Richard Jäger
    • 1
  • Nicolaus Friedrichs
    • 1
  • Inge Heim
    • 1
  • Reinhard Büttner
    • 1
  • Hubert Schorle
    • 1
    • 2
  1. 1.Department of Developmental Pathology, Institute for PathologyUniversity of Bonn Medical SchoolBonnGermany
  2. 2.ZMB, Department of Developmental Biology and PhysiologyUniversity of Duisburg-EssenEssenGermany

Personalised recommendations